To determine whether key proteins involved in the CME pathway were also dysregulated in LRRK2 patients, we stained human post-mortem striatal tissue from PD patients carrying the LRRK2-G2019S mutation and age matched controls. The gene discussed is LRRK2; the disease is Parkinson disease.